Plaque Psoriasis Efficacy and Safety With Secukinumab
Clinical trial NCT02409667 · COMPLETED
Trial details
- NCT number
- NCT02409667
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-07
- Primary completion
- 2017-03-14
- Enrollment
- 16487
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.